Clinical Trial Update: Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating empagliflozin or linagliptin as alternatives to metformin for polycystic ovary syndrome (PCOS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Empagliflozin (empagliflozin)
• Linagliptin (linagliptin)

Snippet

Sponsor: Alexandria University | Conditions: Polycystic Ovary Syndrome (PCOS) | Phase 4 | Status: UNKNOWN